DTIL Precision BioSciences, Inc.

Develops technology to produce custom, genome-editing enzymes for human health and biological research

As of 05/26/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/27/2019
Outstanding shares:  62,176,408
Average volume:  705,693
Market cap:   $96,995,196
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJ0M2S0
Valuation   (See tab for details)
PE ratio:   -2.42
PB ratio:   1.38
PS ratio:   0.95
Return on equity:   -57.54%
Net income %:   -39.10%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy